HomeBiotech

Biotech

Cellares Joins FDA’s Inaugural Manufacturing PreCheck Pilot

Life Sciences Times - June 30, 2026

Biotech

Sarepta’s Duchenne Drug Applications Accepted for FDA Review

Life Sciences Times - June 30, 2026

Biotech

Stoke Therapeutics Completes Enrollment in Phase 3 Dravet Syndrome Trial

Life Sciences Times - June 30, 2026

Biotech

SC Therapeutics Launches Phase 2 Trial of Chronic Cough Therapy

Life Sciences Times - June 30, 2026

Biotech

Consano Bio Highlights Scientific Advisors Supporting Chronic Sciatica Therapy

Life Sciences Times - June 29, 2026

Biotech

Trailblazers: Vertex CEO Reshma Kewalramani on Leadership, STEM, Diversity, Inclusion and Medicine on Chai With Manju

Life Sciences Times - December 11, 2020 0

Biotech

Cell Isolation/ Separation Market Worth $15.0 Billion by 2025

Life Sciences Times - December 11, 2020 0

Biotech

LifeX Labs, Pittsburgh Life Sciences Greenhouse Teaming up to Fast-track Startups and Innovators

Life Sciences Times - December 7, 2020 0

Biotech

Life Sciences Leaders Optimistic About Funding Prospects but Cautious About Growth Outlook, New Research Finds

Life Sciences Times - December 7, 2020 0

1...97 9899Page 99 of 99

Cellares Joins FDA’s Inaugural Manufacturing PreCheck Pilot

June 30, 2026

Kinaset Therapeutics Names Daniel Welch Board Chair, Adds David Lubner as Director

June 30, 2026

Exact Imaging Expands U.S. Sales Team Amid Growing Demand for Prostate Imaging System

June 30, 2026

Hengrui’s Heng Yi Approved in China for Dry Eye Disease

June 30, 2026

Biotech

Cellares Joins FDA’s Inaugural Manufacturing PreCheck Pilot

Sarepta’s Duchenne Drug Applications Accepted for FDA Review

Stoke Therapeutics Completes Enrollment in Phase 3 Dravet Syndrome Trial

SC Therapeutics Launches Phase 2 Trial of Chronic Cough Therapy

Consano Bio Highlights Scientific Advisors Supporting Chronic Sciatica Therapy

Most Read

Cellares Joins FDA’s Inaugural Manufacturing PreCheck Pilot

Kinaset Therapeutics Names Daniel Welch Board Chair, Adds David Lubner as Director

Exact Imaging Expands U.S. Sales Team Amid Growing Demand for Prostate Imaging System

Hengrui’s Heng Yi Approved in China for Dry Eye Disease

EDITOR PICKS

Stoke Therapeutics Completes Enrollment in Phase 3 Dravet Syndrome Trial

FDA Approves Viridian Therapeutics’ Lumvoa for Thyroid Eye Disease

PharmaEssentia Launches FDA-Approved BESREMi Pen for Polycythemia Vera

THIS WEEK'S STORIES

FDA Approves Viridian Therapeutics’ Lumvoa for Thyroid Eye Disease

Exact Imaging Expands U.S. Sales Team Amid Growing Demand for Prostate Imaging System

AstraZeneca, YMCA Launch Five-Year Partnership to Expand Cancer Education

POPULAR CATEGORY

ABOUT US

FOLLOW US